Amgen - Statistics & Facts

Biotechnology company Amgen was originally founded as AMGen in 1980, standing for Applied Molecular Genetics. The company is headquartered in Thousand Oaks, California, but has establishments in many other countries around the world. Today, Amgen is the world’s largest pure play biotechnology company, generating nearly 23 billion U.S. dollars of revenue and employing around 19 thousand people worldwide.

Amgen is among the global top 10 pharmaceutical companies based on market value. As of September 2017, the company was worth some 138 billion U.S. dollars. Biopharmaceuticals manufactured by Amgen are also among the leading biotech drugs worldwide. Enbrel and Neulasta are the company’s flagship products, responsible for nearly half of Amgen’s total revenue. Interestingly, Amgen generates almost 80 percent of its revenues on the domestic U.S. market.

As is common in the biopharmaceutical industry, Amgen spends a significant proportion of its income on research and development. In 2017, Amgen spent some 16 percent of its revenue on R&D purposes. Some 25 percent of 3.56 billion dollars of R&D spending was for late-stage clinical programs, while the rest was for discovery research and translational sciences, and for marketed products.

Read more

Amgen - Important statistics

The whole topic in one document

Amgen
  • Edited and prepared
  • Download in PPT/PDF format
  • Instant access
  • From $365

The whole topic in one document

Amgen
  • Edited and prepared
  • Download in PPT/PDF format
  • Instant access
  • From $365

Recommended statistics

More interesting topics from the industry "Pharmaceutical Products & Market"

More interesting topics from the industry "Pharmaceutical Products & Market"

About Statista

Learn more about how Statista can support your business.

Request webinar

Any more questions?

Any more questions?

Get in touch with us quickly and easily. We are happy to help!

Get in touch with us quickly and easily. We are happy to help!

Do you still have questions?

Feel free to contact us anytime using our contact form or visit our FAQ page.

News